Clinical trials
Hepatitis B, Chronic trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
144 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 3 |
| 2007 | 9 |
| 2008 | 6 |
| 2009 | 9 |
| 2010 | 7 |
| 2011 | 4 |
| 2012 | 8 |
| 2013 | 8 |
| 2014 | 6 |
| 2015 | 13 |
| 2016 | 5 |
| 2017 | 9 |
| 2018 | 11 |
| 2019 | 3 |
| 2020 | 11 |
| 2021 | 8 |
| 2022 | 5 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 94 |
| Unknown status | 26 |
| Terminated | 14 |
| Active, not recruiting | 6 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 12 |
| Hoffmann-La Roche | 11 |
| GlaxoSmithKline | 9 |
| Yonsei University | 9 |
| Bukwang Pharmaceutical | 8 |
| Bristol-Myers Squibb | 6 |
| Chong Kun Dang Pharmaceutical | 6 |
| Korea University | 5 |
| Novartis Pharmaceuticals | 5 |
| Seoul National University Hospital | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis B, Chronic | 144 |
| Hepatitis B | 27 |
| Hepatitis | 12 |
| Hepatitis, Chronic | 4 |
| Liver Cirrhosis | 4 |
| DNA Virus Infections | 3 |
| Fatty Liver | 3 |
| Fibrosis | 3 |
| Liver Diseases | 3 |
| Chronic Disease | 2 |
Trials
Showing 1 to 25 of 144. Each trial links to its page on Pharma Observatory.
44 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.